Declaration of interest
None of the authors have any relevant conflicts of interest to report. Dr. El-Mallakh has received research funding from Janssen and Sage, and is a speaker for Allergan, Janssen, Lundbeck, Neurocrine, Otsuka, Takeda, and Teva. The other authors have no conflicts of interest.
The contents of the paper and the opinions expressed within are those of the authors, and it was the decision of the authors to submit the manuscript for publication.
Reviewers disclosure
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.